In the last decades, the peroxisome proliferator-activated receptor γ (PPARγ), a ligand-activated transcription factor, which has been mainly characterized as a pivotal regulator of adipocyte differentiation, has also received considerable attention for its role in breast cancer tumorigenesis [13,14]. This evidence concerns the gene PPARG and breast cancer.